Literature DB >> 24716905

Correlation between expression of cell adhesion molecules CD₄₄ v6 and E-cadherin and lymphatic metastasis in non- small cell lung cancer.

Chong-Yu Su1, Yun-Song Li, Yi Han, Shi-Jie Zhou, Zhi-Dong Liu.   

Abstract

OBJECTIVE: To explore the relationship between expressions of cell adhesion molecules CD44 v6 and E-cadherin (E-cad) and lymphatic metastasis in non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: Eighty- seven tissue samples obtained from patients with primary NSCLC were collected in our hospital from Dec., 2007 to Dec., 2012, and the expressions of CD44 v6 and E-cad gene proteins in these samples were detected by immunohistochemical method.
RESULTS: In the tissue without lymphatic metastasis, the positive expression rate of CD44 v6 was significantly lower, whereas the normal expression rate of E-cad was notably higher than that with lymphatic metastasis (55.6% vs. 78.4%, 47.2% vs. 21.6%), and both differences had statistical significance (P<0.05). Besides, CD44 v6 and E-cad expressions had a significant correlation in the NSCLC tissue with lymphatic metastasis (P<0.05).
CONCLUSIONS: The positive expression of CD44 v6 and abnormal expression of E-cad may play a very important role in promoting lymphatic metastasis of NSCLC, with synergistic effect. Hence, detection of CD44 v6 and E-cad expressions is conductive to judging the lymphatic metastasis in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24716905     DOI: 10.7314/apjcp.2014.15.5.2221

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  The clinicopathological significance and potential drug target of E-cadherin in NSCLC.

Authors:  Kaize Zhong; Weiwen Chen; Ning Xiao; Jian Zhao
Journal:  Tumour Biol       Date:  2015-03-11

2.  Detailed assessment of microvasculature markers in non-small cell lung cancer reveals potentially clinically relevant characteristics.

Authors:  Geoffrey Pomme; Florian Augustin; Michael Fiegl; Raoul A Droeser; William Sterlacci; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2015-04-09       Impact factor: 4.064

3.  Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.

Authors:  Y Zhang; L F Wang; J H Gao; L Li; P Jiang; X Lv; L X Yu; J Yang; R T Li; B R Liu
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

4.  Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.

Authors:  Lingmei Li; Lisha Qi; Zhijie Liang; Wangzhao Song; Yanxue Liu; Yalei Wang; Baocun Sun; Bin Zhang; Wenfeng Cao
Journal:  Int J Mol Med       Date:  2015-05-25       Impact factor: 4.101

Review 5.  Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review.

Authors:  Qiaowen Yu; Qisen Guo; Liangan Chen; Shuwei Liu
Journal:  Drug Des Devel Ther       Date:  2015-04-15       Impact factor: 4.162

Review 6.  The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review.

Authors:  Wei Zeng; Jinfeng Zhu; Li Shan; Zhigang Han; Patiguli Aerxiding; Amina Quhai; Fanye Zeng; Ziwei Wang; Huiwu Li
Journal:  Drug Des Devel Ther       Date:  2015-04-13       Impact factor: 4.162

7.  C3G dynamically associates with nuclear speckles and regulates mRNA splicing.

Authors:  Dhruv Kumar Shakyawar; Bhattiprolu Muralikrishna; Vegesna Radha
Journal:  Mol Biol Cell       Date:  2018-05-01       Impact factor: 4.138

8.  RNA-binding protein CELF6 modulates transcription and splicing levels of genes associated with tumorigenesis in lung cancer A549 cells.

Authors:  HuSai Ma; GuoWei Liu; Bin Yu; Joshua Wang; YaLi Qi; YiYing Kou; Ying Hu; ShunJun Wang; Fei Wang; Dong Chen
Journal:  PeerJ       Date:  2022-07-26       Impact factor: 3.061

9.  Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma.

Authors:  Alison L Halpern; Patrick D Kohtz; Jessica Y Rove; Lihua Ao; Xianzhong Meng; David A Fullerton; Michael J Weyant
Journal:  Mol Cell Biochem       Date:  2019-01-25       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.